Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx, The University of California, BioForce Nanosciences


Zyomyx, of Hayward, Calif., has received US Patent No. 6,576,478, “Microdevices for high-throughput screening of biomolecules.” The patent covers microfabricated, miniaturized devices that screen biomolecular activity in parallel. The biomolecules are immobilized on the device’s surface. These biomolecules include proteins, polypeptides, nucleic acids, polysaccharides, phospholipids, as well as biologically relevant unnatural polymers. The device is to be used for clinical diagnostics and high-throughput screening, especially for parallel screening of families of related proteins.


The University of California has received US Patent No. 6,576,459, “Sample preparation and detection device for infectious agents.” The device, invented by Robin Miles and others, is a compact microchip that is portable in the field, and incorporates PCR assays and immunoassays. It can be built as a fluidic chip with no moving parts, and incorporates magnetohydrodynamic pumps to move fluid through the system, acoustic mixing and fractionation, dielectropheretic sample concentration and purification, as well as on-chip optical detection. It can operate in a continuous mode.


BioForce Nanosciences received US patent No. 6,573,369, “Method and Apparatus for Solid State Molecular Analysis.” The patent covers a method for the formation and analysis of novel miniature deposition domains that are placed on a surface to form a molecular array. The molecular array is scanned with an AFM to analyze molecular recognition events and the effect of introduced agents on defined molecular interactions. The patent claims that this approach can be carried out in a high-throughput format, allowing rapid screening of thousands of molecular species in a solid state array. The invention does not require the labeling of the deposition material or the target sample and may also be used to deposit large size molecules without harming the same.


The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.